| Date | Time | Source | Headline | Symbol | Company |
| 10/26/2021 | 6:59AM | Business Wire | Crestwood to Acquire Oasis Midstream Partners in $1.8 Billion Transaction | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/25/2013 | 8:00AM | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Completes Tender Offer for Obagi Medical Products, Inc. | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/24/2013 | 8:00AM | PR Newswire (US) | Valeant Pharmaceuticals International, Inc. Announces Receipt of Approval From the Antimonopoly Committee of Ukraine for its... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/23/2013 | 8:00AM | PR Newswire (US) | Valeant Pharmaceuticals Announces Extension of the Expiration Date for Its Previously Announced Tender Offer for All Outstand... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/22/2013 | 8:00AM | PR Newswire (US) | Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance In The United States For Its Previously Announced Acquisitio... | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/17/2013 | 4:28PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/12/2013 | 5:30PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/12/2013 | 5:17PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/12/2013 | 5:17PM | Edgar (US Regulatory) | Post-effective Amendment (investment Company, Rule 485(a)) (485apos) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/09/2013 | 10:43AM | Zacks | Valeant: The Sole Suitor for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/08/2013 | 9:20AM | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/08/2013 | 8:22AM | Dow Jones News | Merz Pharma Withdraws Offer for Obagi Medical After Valeant's Sweetened Bid | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/08/2013 | 7:32AM | PR Newswire (US) | Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/05/2013 | 4:56PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/05/2013 | 4:49PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/04/2013 | 5:20PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/04/2013 | 1:50PM | Zacks | Valeant Ups Offer for Obagi - Analyst Blog | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/04/2013 | 6:02AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 5:19PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 2:51PM | GlobeNewswire Inc. | CORRECTING and REPLACING -- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 1:47PM | GlobeNewswire Inc. | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Obagi Medic | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 11:26AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 9:13AM | Dow Jones News | U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 9:02AM | Dow Jones News | Valeant Boosts Price for Obagi to $420 Million, Besting Merz Offer | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 8:00AM | PR Newswire (US) | Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/03/2013 | 8:00AM | Business Wire | Obagi Medical Products, Inc. and Valeant Pharmaceuticals, Inc. Agree on an Increased Offer Price of $24.00 per Share in Cash | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/02/2013 | 5:18PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/02/2013 | 4:22PM | Edgar (US Regulatory) | Written Communication Relating to an Issuer or Third Party (sc To-c) | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/02/2013 | 1:42PM | Dow Jones News | UPDATE: Merz Pharma Offers to Buy Obagi, Looks to Top Valeant Deal | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |
| 04/02/2013 | 12:30PM | Business Wire | Board of Directors of Obagi Medical Products, Inc. Receives Unsolicited Acquisition Proposal from Merz Pharma | NASDAQ:OMPI | Obagi Medical Products, Inc. (MM) |